Jianghua Tu

759 total citations
17 papers, 582 citations indexed

About

Jianghua Tu is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Jianghua Tu has authored 17 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Jianghua Tu's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jianghua Tu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (7 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Jianghua Tu collaborates with scholars based in China, United States and Germany. Jianghua Tu's co-authors include Zhi‐Rong Tan, Gan Zhou, Yao Chen, Lan Fan, Hong‐Hao Zhou, Dongli Hu, Yijing He, Zhaoqian Liu, Ling Wu and Kendra S. Carmon and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Clinica Chimica Acta.

In The Last Decade

Jianghua Tu

17 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jianghua Tu China	13	243	197	167	129	60	17	582
Francis Heitz Switzerland	8	207 0.9×	213 1.1×	200 1.2×	118 0.9×	36 0.6×	8	855
Kushari Bowalgaha Australia	8	301 1.2×	168 0.9×	141 0.8×	73 0.6×	48 0.8×	8	455
Andrea Soldner United States	9	200 0.8×	219 1.1×	178 1.1×	119 0.9×	16 0.3×	10	681
Sang Seop Lee South Korea	20	326 1.3×	327 1.7×	237 1.4×	121 0.9×	13 0.2×	40	859
Peng Wen-xing China	19	145 0.6×	106 0.5×	194 1.2×	44 0.3×	12 0.2×	53	847
Shunsuke Iwano Japan	18	282 1.2×	187 0.9×	183 1.1×	54 0.4×	17 0.3×	26	580
Matthew D. Harwood United Kingdom	13	303 1.2×	454 2.3×	148 0.9×	211 1.6×	18 0.3×	22	717
Yumiko Akamine Japan	12	134 0.6×	230 1.2×	56 0.3×	203 1.6×	25 0.4×	44	487
Tung‐Wei Hung Taiwan	18	53 0.2×	64 0.3×	308 1.8×	52 0.4×	43 0.7×	50	804

Countries citing papers authored by Jianghua Tu

Since Specialization

Citations

This map shows the geographic impact of Jianghua Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianghua Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianghua Tu more than expected).

Fields of papers citing papers by Jianghua Tu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianghua Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianghua Tu. The network helps show where Jianghua Tu may publish in the future.

Co-authorship network of co-authors of Jianghua Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianghua Tu. A scholar is included among the top collaborators of Jianghua Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianghua Tu. Jianghua Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tu, Jianghua, Yukimatsu Toh, Jake J. Wen, et al.. (2024). Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma. Pharmaceutics. 16(7). 943–943. 3 indexed citations

Toh, Yukimatsu, Ling Wu, Soo-Hyun Park, et al.. (2023). LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43/ZNRF3 to provide high affinity binding of R-spondin ligands. Scientific Reports. 13(1). 10796–10796. 9 indexed citations

Cui, Jie, Yukimatsu Toh, Soo-Hyun Park, et al.. (2021). Drug Conjugates of Antagonistic R-Spondin 4 Mutant for Simultaneous Targeting of Leucine-Rich Repeat-Containing G Protein-Coupled Receptors 4/5/6 for Cancer Treatment. Journal of Medicinal Chemistry. 64(17). 12572–12581. 10 indexed citations

Park, Soo-Hyun, Ling Wu, Jianghua Tu, et al.. (2020). Unlike LGR4, LGR5 potentiates Wnt–β-catenin signaling without sequestering E3 ligases. Science Signaling. 13(660). 28 indexed citations

Tu, Jianghua, Soo-Hyun Park, Wangsheng Yu, et al.. (2019). The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis. Scientific Reports. 9(1). 18557–18557. 46 indexed citations

Li, Peng, Yaling Yin, Jianghua Tu, et al.. (2015). Rosiglitazone via PPARγ‐dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone. Journal of Cellular and Molecular Medicine. 19(4). 826–835. 36 indexed citations

Tu, Jianghua, Yijing He, Yao Chen, et al.. (2010). Effect of glycyrrhizin on the activity of CYP3A enzyme in humans. European Journal of Clinical Pharmacology. 66(8). 805–810. 56 indexed citations

Tu, Jianghua, Dongli Hu, Lingling Dai, et al.. (2010). Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes. Xenobiotica. 40(6). 393–399. 31 indexed citations

Chen, Yao, Peng Xiao, Dongsheng Ouyang, et al.. (2009). SIMULTANEOUS ACTION OF THE FLAVONOID QUERCETIN ON CYTOCHROME P450 (CYP) 1A2, CYP2A6, N‐ACETYLTRANSFERASE AND XANTHINE OXIDASE ACTIVITY IN HEALTHY VOLUNTEERS. Clinical and Experimental Pharmacology and Physiology. 36(8). 828–833. 56 indexed citations

10.

Li, Z., Guanchao Wang, Wei Zhang, et al.. (2009). Effects of theCYP2C9*13allele on the pharmacokinetics of losartan in healthy male subjects. Xenobiotica. 39(10). 788–793. 28 indexed citations

11.

Chen, Bi‐Lian, Yao Chen, Jianghua Tu, et al.. (2009). Clopidogrel Inhibits CYP2C19‐Dependent Hydroxylation of Omeprazole Related to CYP2C19 Genetic Polymorphisms. The Journal of Clinical Pharmacology. 49(5). 574–581. 33 indexed citations

12.

He, Yijing, Wei Zhang, Yao Chen, et al.. (2009). Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism. Clinica Chimica Acta. 405(1-2). 49–52. 70 indexed citations

13.

Chen, Yao, Jianghua Tu, Yijing He, et al.. (2009). Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers. Xenobiotica. 39(7). 508–513. 25 indexed citations

14.

He, Yijing, Jianghua Tu, Julia Kirchheiner, et al.. (2008). Hepatic Nuclear Factor 1α Inhibitor Ursodeoxycholic Acid Influences Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 Substrate Rosuvastatin and Bilirubin. Drug Metabolism and Disposition. 36(8). 1453–1456. 24 indexed citations

15.

Hu, Yuqing, Jianghua Tu, Zhi‐Rong Tan, et al.. (2007). Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects. Xenobiotica. 37(3). 315–327. 52 indexed citations

16.

Yong-fang, HU, Wen Qiu, Zhaoqian Liu, et al.. (2006). EFFECTS OF GENETIC POLYMORPHISMS OFCYP3A4,CYP3A5ANDMDR1ON CYCLOSPORINE PHARMACOKINETICS AFTER RENAL TRANSPLANTATION. Clinical and Experimental Pharmacology and Physiology. 33(11). 1093–1098. 72 indexed citations

17.

Tu, Jianghua, Liying Liu, & Xiaohong Zhang. (2002). [Protective effect of Na(+)-H+ exchanger inhibitor cariporide on the injury of vascular endothelial function induced by hypercholesterolemia].. PubMed. 27(1). 13–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact